The global cold laser therapy market is experiencing remarkable growth, fueled by a growing demand for advanced therapeutic solutions. According to a recent market analysis by Future Market Insights (FMI), the market is projected to reach a valuation of USD 180.8 million by 2033, marking a significant rise from USD 117.1 million expected by the end of 2023. This robust growth represents a Compound Annual Growth Rate (CAGR) of 4.4% over the forecast period.
A key trend highlighted in the report is the dominance of continuous laser devices, which are anticipated to account for a commanding 55.6% market share in 2023. Continuous laser technology is becoming a cornerstone in therapeutic applications, underscoring its critical role in the cold laser therapy industry.
“This substantial growth underscores the industry’s shift towards innovative therapeutic solutions,” commented FMI. “Continuous laser devices are preferred for their effectiveness and reliability in therapeutic treatments, driving their widespread adoption across various medical settings.”
Cold laser therapy, also known as low-level laser therapy (LLLT), is a non-invasive treatment option used for pain management, tissue repair, and a variety of other medical conditions. The market’s expansion is further propelled by increasing awareness among healthcare providers and patients about the benefits of non-pharmacological treatments.
With its potential to revolutionize pain management and tissue healing, the cold laser therapy market is poised for continued success, as both technological advancements and the demand for safer, drug-free treatments fuel its growth trajectory.
Key Takeaways: Cold Laser Therapy Market
- The global cold laser therapy market is expected to reach USD 180.8 million by 2033, growing at a CAGR of 4.4%.
- Continuous laser devices dominate the market, holding a projected 55.6% share in 2023.
- The US holds the largest market share (36.5% in 2023) due to a strong healthcare infrastructure and focus on innovative technologies.
- New Technologies: Advancements like the MicroPulse P3 device for glaucoma treatment by IRIDEX Corporation exemplify how innovation drives market growth.
- Rising awareness of cold laser therapy benefits (pain relief, musculoskeletal disorders) and its use in home healthcare settings fuel market expansion in Germany (6.4% share in 2023).
- A long history of laser medicine research and established safety protocols in Japan (5.6% share in 2023) create a strong foundation for market growth.
Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis!
Competitive Landscape:
Manufacturers are aiming to expand their market share by focusing on developing innovative Cold Laser Therapy technology at competitive prices. Key strategies to enhance revenue include launching new products through robust R&D efforts to strengthen their product portfolios.
Examples of significant industry strategies in the cold laser therapy market include:
- Apira Science Inc. received approvals from the Korea Food and Drug Administration (KFDA), FDA Thailand, Egyptian Ministry of Health (MoHP), and Singapore Health Sciences Authority (HSA) in January 2018 to introduce iGrow’s advanced low-level light treatment (LLLT) technology in these markets.
- In March 2021, B-Cure Laser launched a handheld laser therapy device, B-Cure Laser, in the United Kingdom, providing relief to chronic pain sufferers.
Top Key Companies Profiled:
- Apira Science Inc.
- B-Cure laser Australia
- Erchonia Corporation
- Theralase Inc.
- DJO Global, Inc. (Colfax Corporation)
- BTL Corporate
- BioLight Technologies LLC
- THOR Photomedicine Ltd
- Irradia
- PhotoMedex
- Lexington International, LLC
- MICROLIGHT Corporation
- Apollo (Pivotal Health Care LLC)
Key Market Segments Covered in Cold Laser Therapy Industry Research:
By Product:
- Continuous Laser Devices
- Pulse Laser Devices
- Combination Laser Devices
By Technology:
- Single Wavelength Cold Laser Therapy Devices
- Multiple Wavelength Cold Laser Therapy Devices
By Application:
- Pain Management
- Arthritis
- Wound Healing
- Nerve Regeneration
- Dermatology
- Musculoskeletal
- Others
By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Homecare Settings
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
